These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 7519173)

  • 1. Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release.
    Stewart AG; Cotterill T; Harris T
    Immunology; 1994 May; 82(1):51-6. PubMed ID: 7519173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M
    Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.
    Stewart AG; Harris T; De Nichilo M; Lopez AF
    Immunology; 1991 Feb; 72(2):206-12. PubMed ID: 1849872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.
    Kodama T; Hazeki K; Hazeki O; Okada T; Ui M
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):201-9. PubMed ID: 9882616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming for the synthesis of 5-lipoxygenase products in human blood ex vivo by human granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha.
    Palmantier R; Surette ME; Sanchez A; Braquet P; Borgeat P
    Lab Invest; 1994 May; 70(5):696-704. PubMed ID: 8196365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human G-CSF and GM-CSF prime human neutrophils for superoxide production through different signal transduction mechanisms.
    Balazovich KJ; Almeida HI; Boxer LA
    J Lab Clin Med; 1991 Dec; 118(6):576-84. PubMed ID: 1720802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
    Wirthmueller U; De Weck AL; Dahinden CA
    J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on respiratory burst activity of neutrophils in patients with myelodysplastic syndromes.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Furusawa S; Miura Y; Takaku F; Saito M
    Clin Exp Immunol; 1993 Feb; 91(2):308-13. PubMed ID: 7679062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.
    Stewart AG; Harris T
    Immunology; 1993 Jan; 78(1):152-8. PubMed ID: 8382188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5.
    Brunner T; de Weck AL; Dahinden CA
    J Immunol; 1991 Jul; 147(1):237-42. PubMed ID: 1711077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity.
    Sullivan GW; Carper HT; Mandell GL
    Blood; 1993 Apr; 81(7):1863-70. PubMed ID: 7681704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human granulocyte-macrophage colony-stimulating factor and other cytokines prime human neutrophils for enhanced arachidonic acid release and leukotriene B4 synthesis.
    DiPersio JF; Billing P; Williams R; Gasson JC
    J Immunol; 1988 Jun; 140(12):4315-22. PubMed ID: 2453577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The loss of recombinant human granulocyte colony-stimulating factor and recombinant human TNF-alpha priming effects on the superoxide-generating response in exudated neutrophils is associated with a decrease in their receptor affinities.
    Niwa M; Yousif AE; Kohno K; Kanamori Y; Matsuno M; Abe A; Uematsu T
    J Immunol; 1996 Nov; 157(9):4147-53. PubMed ID: 8892651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming of the human neutrophil respiratory burst by granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha involves regulation at a post-cell surface receptor level. Enhancement of the effect of agents which directly activate G proteins.
    McColl SR; Beauseigle D; Gilbert C; Naccache PH
    J Immunol; 1990 Nov; 145(9):3047-53. PubMed ID: 2170531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate inhibits superoxide production and chemotaxis in neutrophils activated by granulocyte colony-stimulating factor.
    Okuda A; Kubota M; Sawada M; Koishi S; Kataoka A; Bessho R; Usami I; Lin YW; Adachi S; Furusho K
    J Cell Physiol; 1996 Jul; 168(1):183-7. PubMed ID: 8647914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and priming of human monocytes by monocyte chemotactic activating factor: cooperation with other inflammatory cytokines and close association between an increase in cytoplasmic free Ca2+ and intracellular acidification.
    Azuma EK; Yuo A; Matsushima T; Kasahara T; Mizoguchi H; Saito M; Takaku F; Kitagawa S
    Exp Hematol; 1996 Feb; 24(2):169-75. PubMed ID: 8641338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An inhibitor of ornithine decarboxylase antagonizes superoxide generation by primed human polymorphonuclear leukocytes.
    Walters JD; Cario AC; Danne MM; Marucha PT
    J Inflamm; 1998; 48(1):40-6. PubMed ID: 9368191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of granulocyte-macrophage colony-stimulating factor on eosinophil and neutrophil superoxide anion generation.
    Nagata M; Sedgwick JB; Busse WW
    J Immunol; 1995 Nov; 155(10):4948-54. PubMed ID: 7594500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of platelet-activating factor-induced leukotriene synthesis in neutrophils by granulocyte-macrophage colony-stimulating factor (GM-CSF): studies on the mechanism of action of GM-CSF.
    McColl SR; Krump E; McDonald PP; Braquet M; Naccache PH; Borgeat P
    J Lipid Mediat; 1990; 2 Suppl():S119-27. PubMed ID: 1966811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.